Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2015

Open Access 01-12-2015 | Case report

A case of failed eradication of cystic fibrosis-related sinus colonisation by Pseudomonas aeruginosa

Authors: Barry Linnane, Linda Kearse, Nuala H. O’ Connell, John Fenton, Miranda G. Kiernan, Colum P. Dunne

Published in: BMC Pulmonary Medicine | Issue 1/2015

Login to get access

Abstract

Background

Pseudomonas aeruginosa is a pathogen associated with cystic fibrosis that has potential to decrease lung function and cause respiratory failure. Paranasal sinuses are increasingly recognised as potential reservoirs for intermittent colonisation by P. aeruginosa. This case documents investigation and outcome of P. aeruginosa recurrence in a male paediatric patient over an eight year period.

Case presentation

A 12 year old Irish male paediatric cystic fibrosis patient experienced intermittent culturing of P. aeruginosa from the oropharyngeal region, indicating chronic infection of the sinuses despite absence of symptoms, retaining good lung function, and normal bronchoscopy and bronchoalveloar lavage. However, P. aeruginosa was isolated from a sinus wash-out and was identified as a unique strain of P. aeruginosa that was also cultured from cough swabs. Despite treatment, successful eradication from the paranasal sinuses was not achieved.

Conclusions

Few reports have addressed the paranasal sinuses as a reservoir for lung infection in cystic fibrosis patients despite increased recognition of the need to investigate this niche. In this case, attempts at eradication of P. aeruginosa present in paranasal sinuses including oral and nebulised antimicrobials proved unsuccessful. However, detection of P. aeruginosa in the paranasal sinuses instigated antimicrobial treatment which may have contributed to prevention of migration to the lower airways. Our outcome provides additional insight and may indicate utility of nasal lavage or nasal endoscopy in paediatric cystic fibrosis patients’ annual review clinic visits.
Literature
9.
go back to reference Muhlebach MS, Miller MB, Moore C, Wedd JP, Drake AF, Leigh MW. Are lower airway or throat cultures predictive of sinus bacteriology in cystic fibrosis? Pediatr Pulmonol. 2006;41(5):445–51. doi:10.1002/ppul.20396.CrossRefPubMed Muhlebach MS, Miller MB, Moore C, Wedd JP, Drake AF, Leigh MW. Are lower airway or throat cultures predictive of sinus bacteriology in cystic fibrosis? Pediatr Pulmonol. 2006;41(5):445–51. doi:10.​1002/​ppul.​20396.CrossRefPubMed
10.
go back to reference Dosanjh A, Lakhani S, Elashoff D, Chin C, Hsu V, Hilman B. A comparison of microbiologic flora of the sinuses and airway among cystic fibrosis patients with maxillary antrostomies. Pediatr Transplant. 2000;4(3):182–5.CrossRefPubMed Dosanjh A, Lakhani S, Elashoff D, Chin C, Hsu V, Hilman B. A comparison of microbiologic flora of the sinuses and airway among cystic fibrosis patients with maxillary antrostomies. Pediatr Transplant. 2000;4(3):182–5.CrossRefPubMed
18.
go back to reference Lindemann RA, Newman MG, Kaufman AK, Le TV. Oral colonization and susceptibility testing of Pseudomonas aeruginosa oral isolates from cystic fibrosis patients. J Dent Res. 1985;64(1):54–7.CrossRefPubMed Lindemann RA, Newman MG, Kaufman AK, Le TV. Oral colonization and susceptibility testing of Pseudomonas aeruginosa oral isolates from cystic fibrosis patients. J Dent Res. 1985;64(1):54–7.CrossRefPubMed
19.
go back to reference Rivas Caldas R, Le Gall F, Revert K, Rault G, Virmaux M, Gouriou S, et al. Pseudomonas aeruginosa and Periodontal Pathogens in the Oral Cavity and Lungs of Cystic Fibrosis Patients: a Case–control Study. J Clin Microbiol. 2015;53(6):1898–907. doi:10.1128/jcm.00368-15.CrossRefPubMedPubMedCentral Rivas Caldas R, Le Gall F, Revert K, Rault G, Virmaux M, Gouriou S, et al. Pseudomonas aeruginosa and Periodontal Pathogens in the Oral Cavity and Lungs of Cystic Fibrosis Patients: a Case–control Study. J Clin Microbiol. 2015;53(6):1898–907. doi:10.​1128/​jcm.​00368-15.CrossRefPubMedPubMedCentral
24.
go back to reference Thomassen MJ, Demko CA, Boxerbaum B, Stern RC, Kuchenbrod PJ. Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis. J Infect Dis. 1979;140(6):873–80.CrossRefPubMed Thomassen MJ, Demko CA, Boxerbaum B, Stern RC, Kuchenbrod PJ. Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis. J Infect Dis. 1979;140(6):873–80.CrossRefPubMed
31.
32.
go back to reference Valerius NH, Koch C, Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet. 1991;338(8769):725–6.CrossRefPubMed Valerius NH, Koch C, Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet. 1991;338(8769):725–6.CrossRefPubMed
34.
go back to reference Berlana D, Llop JM, Manresa F, Jodar R. Outpatient treatment of Pseudomonas aeruginosa bronchial colonization with long-term inhaled colistin, tobramycin, or both in adults without cystic fibrosis. Pharmacotherapy. 2011;31(2):146–57. doi:10.1592/phco.31.2.146.CrossRefPubMed Berlana D, Llop JM, Manresa F, Jodar R. Outpatient treatment of Pseudomonas aeruginosa bronchial colonization with long-term inhaled colistin, tobramycin, or both in adults without cystic fibrosis. Pharmacotherapy. 2011;31(2):146–57. doi:10.​1592/​phco.​31.​2.​146.CrossRefPubMed
35.
go back to reference Herrmann G, Yang L, Wu H, Song Z, Wang H, Hoiby N, et al. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa. J Infect Dis. 2010;202(10):1585–92. doi:10.1086/656788.CrossRefPubMed Herrmann G, Yang L, Wu H, Song Z, Wang H, Hoiby N, et al. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa. J Infect Dis. 2010;202(10):1585–92. doi:10.​1086/​656788.CrossRefPubMed
38.
go back to reference Di Cicco M, Alicandro G, Claut L, Cariani L, Luca N, Defilippi G, et al. Efficacy and tolerability of a new nasal spray formulation containing hyaluronate and tobramycin in cystic fibrosis patients with bacterial rhinosinusitis. J Cyst Fibros. 2014;13(4):455–60. doi:10.1016/j.jcf.2014.02.006.CrossRefPubMed Di Cicco M, Alicandro G, Claut L, Cariani L, Luca N, Defilippi G, et al. Efficacy and tolerability of a new nasal spray formulation containing hyaluronate and tobramycin in cystic fibrosis patients with bacterial rhinosinusitis. J Cyst Fibros. 2014;13(4):455–60. doi:10.​1016/​j.​jcf.​2014.​02.​006.CrossRefPubMed
Metadata
Title
A case of failed eradication of cystic fibrosis-related sinus colonisation by Pseudomonas aeruginosa
Authors
Barry Linnane
Linda Kearse
Nuala H. O’ Connell
John Fenton
Miranda G. Kiernan
Colum P. Dunne
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2015
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-015-0113-0

Other articles of this Issue 1/2015

BMC Pulmonary Medicine 1/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.